SignatureFD’s Zymergen Inc. Common Stock ZY Stock Holding History

SignatureFD’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-125	Closed	-$5K	–	3282
2021 Q2	$5K	Buy	+125	New	+$4.93K	﹤0.01%	2321

Other funds holding ZY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

SignatureFD's ZY Position: Q3 2021 in Review

SignatureFD sold out of Zymergen Inc. Common Stock (ZY) in Q3 2021, closing a stake of 125 shares — an estimated $5K sold.

SignatureFD first reported a position in ZY in Q2 2021 and held it in 1 quarter. The position peaked at $5K in Q2 2021. 71 funds tracked by Wall St. Rank hold ZY as of Q3 2021.

SignatureFD reported no remaining Zymergen Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
SignatureFD sold 125 Zymergen Inc. Common Stock shares in Q3 2021, an estimated $5K.
SignatureFD first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 1 quarter.
SignatureFD's Zymergen Inc. Common Stock position peaked at $5K in Q2 2021.
71 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q3 2021.

Based on SignatureFD's 13F filing for Q3 2021, filed 28 Oct 2021.